维普期刊资源整合服务平台（V6.5）

36篇 您的检索式：作者名="Reiberger T"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic pa- tients with haemodynamic non-response to propranolol显示文摘	Reiberger T Ulbrich G Ferlitsch A	2013	Gut2013，62，11：	1
2	The effects of sorafenib on the portal hypertensive syndrome in patients with liver cirrhosis and hepatocellular carcinoma-a pilot study显示文摘	Pinter M Sieghart W Reiberger T	2012	Aliment Pharmacol Ther2012，35，1：	1
3	Sor- afenib attenuates the portalhypertensive syndrome in partial portal vein ligated rats 显示文摘	REIBERGER T ANGERMAYR B SCHWABL P	2009	Hepatol2009，51，：	1
4	An orthotopic mouse model of hepatocellular carcinoma with underlying liver cirrhosis 显示文摘	Reiberger T Chen Y Ramjiawan RR	2015	Nat Protoc2015，10，8：	1
5	Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol显示文摘	REIBERGER T ULBRICH G FERLITSCH A	2013	Gut2013，62，11：	1
6	Sorafenib at- tenuates the portalhypertensive syndrome in partial portal vein ligated rats 显示文摘	Reiberger T Angermayr B Schwabl P	2009	Hepatol2009，51，5：	1
7	Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats 显示文摘	Reiberger T Angermayr B Schwabl P	2009	J Hepatol2009，51，5：	1
8	Successful HCV eradication and inhibition of HIV replication by intravenous silibinin in an HIV-HCV coinfected patient显示文摘	Payer BA Reiberger T Rutter K	2010	J Clin Virol2010，49，2：	1
9	The effects of sorafenib on the portal hypertensive syndrome in patients with liver cirrhosis and hepatocellular carcinoma-a pilot study 显示文摘	Pinter M Sieghart W Reiberger T	2012	Aliment Pharmacol Ther2012，35，1：	1
10	Portal pressure predicts outcome and safety of antiviral therapy in cirrhotic patients with hepatitis C virus infection显示文摘	Reiberger T Rutter K Ferlitsch A	2011	Clin Gastroenterol Hepatol2011，9，7：	1
11	von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis 显示文摘	Ferlitsch M Reiberger T Hoke M	2012	Hepatology2012，56，4：	1
12	Carvedilol tbr primary prophylaxis of variceal bleeding in cirrhotic patients with haemody- namic non-response to propranolol 显示文摘	Reiberger T Ulbrich G Ferlitsch A	2013	Gut2013，62，11：	1
13	Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic pa- tients with haemodynamic non - response to propranolol 显示文摘	REIBERGER T ULBRICH G FERLITSCH A	2013	Gut2013，62，11：	1
14	Sorafenib atten-uates the portalhypertensive syndrome in partial portal vein ligated rats显示文摘	Reiberger T Angermayr B Schwabl P	2009	J Hepatol2009，51，5：	1
15	The influence of portal pressure on the discordance between absolute CD4 cell count and CD4 cell percentage in HIV/hepatitis C virus-coinfected patients显示文摘	Mandorfer M Reiberger T Paver BA	2013	Clin Infect Dis2013，56，：	1
16	von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis 显示文摘	Ferlitsch M Reiberger T Hoke M	2012	Hepatology2012，56，4：	1
17	HIVHW co-infected patients with low CD4^+ cell nadirs are at risk for faster fibrosis progression and portal hypertension显示文摘	Reiberger T Ferlilsch A sieghart W	2009	Viral Hepat2009，25，：	1
18	Non-selective beta-blockers improve the correlation of liver stiffness and portal pressure in advanced cirrhosis 显示文摘	Reiberger T Ferlitsch A Payer BA	2012	J Gastroenterol2012，47，5：	1
19	Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non response to propranolol 显示文摘	Reiberger T Ulbrieh G Ferlitsch A	2013	Gut2013，6201，：	1
20	Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol 显示文摘	Reiberger T Ulbrich G Ferlitseh A	2013	Gut2013，62，11：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示